Profile
Thomas Kudsk Larsen is currently Head-Investor Relations at Sanofi since 2024.
Formerly, Mr. Larsen was Head-Communication & Investor Relations at Swedish Orphan Biovitrum AB from 2021 to 2023, Head-Investor Relations North America at Roche Holdings, Inc. from 2011 to 2014, and Investor Relations Contact at AstraZeneca PLC.
Mr. Larsen completed undergraduate studies at Copenhagen Business School.
Thomas Kudsk Larsen active positions
| Companies | Position | Start |
|---|---|---|
| SANOFI | Investor Relations Contact | 2024-03-14 |
Former positions of Thomas Kudsk Larsen
| Companies | Position | End |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Investor Relations Contact | 2023-03-31 |
| ASTRAZENECA PLC | Investor Relations Contact | 2021-07-31 |
Roche Holdings, Inc.
Roche Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures and sells pharmaceuticals, diagnostic instruments, reagents & consumables | Investor Relations Contact | 2014-08-31 |
Education of Thomas Kudsk Larsen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Roche Holdings, Inc.
Roche Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures and sells pharmaceuticals, diagnostic instruments, reagents & consumables | Health Technology |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Copenhagen Business School
Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
- Stock Market
- Insiders
- Thomas Kudsk Larsen
















